Clinical Trials Act

Section 19A: Accredited principal investigators

PART IVA: PUBLIC CLINICAL TRIAL UNIT AND NATIONAL CLINICAL TRIAL NETWORK

Clinical Trials ActSection 19A

19A. Accredited principal investigators (1) The Council shall establish and maintain a register of accredited principal investigators. (2) The Council may accredit an investigator as an accredited principal investigator where the investigator – (a) is registered as a specialist under the Medical Council Act or has not less than 10 years’ post-registration clinical experience in the relevant field of practice; (b) maintains current good clinical practice certification recognised by the Council; and (c) has acted as principal investigator in at least one multinational clinical trial approved by a recognised regulatory authority or has acted as principal investigator in not less than 3 clinical trials approved by the Council. (3) An accreditation shall be valid for a period of 5 years and may be renewed for further periods of 5 years. Acts 2026 325 (4) The Council may suspend or revoke an accreditation where an accredited principal investigator fails to comply with this Act, any regulations made under it, the conditions of a trial licence or the principles of good clinical practice. (5) Every clinical trial conducted through the Public Clinical Trial Unit shall be under the overall supervision of an accredited principal investigator, unless the Council determines otherwise in writing. (n) by repealing section 34 and replacing it by the following section –

This section is inserted by The Economic and Financial Measures (Miscellaneous Provisions) Act 2026, section 8.

Came into operation on 13 August 2026 (Gazette date; the Act states no other date for this provision).

consolidated text (as at 2017, amended since). juris shows the text as it was consolidated; it does not confirm that this is the law in force today.

Ask juris about this section Official source